{"id":515006,"date":"2021-07-20T08:13:01","date_gmt":"2021-07-20T12:13:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/"},"modified":"2021-07-20T08:13:01","modified_gmt":"2021-07-20T12:13:01","slug":"fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/","title":{"rendered":"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic"},"content":{"rendered":"<p>        <!--.bwlistdecimal { list-style-type: decimal }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic<\/b><\/p>\n<p><i>Selected Recipients of the New \u201cBack to Screening Award for Research Advocacy Excellence\u201d will be Honored at Fight Colorectal Cancer\u2019s \u201cPath to a Cure\u201d Event in December 2021<\/i><\/p>\n<p>SPRINGFIELD, Mo. &amp; REDWOOD CITY, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nFight Colorectal Cancer (Fight CRC), the nation&#8217;s leading colorectal cancer (CRC) patient advocacy organization, and Guardant Health, Inc. (Nasdaq: GH), a leader in precision oncology, will be recognizing clinical researchers and advocates who have demonstrated exceptional leadership during the pandemic in getting people back to routine colorectal cancer screening.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20210720005424\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210720005424\/en\/<\/a><\/p>\n<p>\nThe award, called \u201cBack to Screening Award for Research Advocacy Excellence,\u201d will honor key contributions made by Fight CRC research advocates, as well as Principal Investigators participating in Guardant Health\u2019s ECLIPSE trial, a clinical study evaluating the use of a blood test to screen for colorectal cancer. Selected recipients of the award will be honored at Fight CRC\u2019s \u201cPath to a Cure\u201d event in December 2021. Notably, this year\u2019s event will convene a group of research and advocacy experts who will be tasked with mapping out a path leading to a cure for colorectal cancer. The framework will be shared with the National Cancer Institute (NCI) and National Institutes of Health (NIH) to request action to help achieve this goal.\n<\/p>\n<p>\n\u201cThe COVID-19 pandemic forced colorectal cancer screening to a standstill in some communities. The data shows drastic declines in 2020, compared to the same timepoints in prior pre-pandemic years,\u201d said Anjee Davis, President of Fight CRC. \u201cDespite these challenges, herculean efforts were made by Fight CRC research advocates and Principal Investigators participating in the ECLIPSE trial to continue to move the needle forward to improve colorectal cancer screening rates and, ultimately, save lives. Fight CRC and Guardant Health have been focused on our shared goal of getting people back to routine cancer screening after the pandemic.\u201d\n<\/p>\n<p>\nThe <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04136002&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=ECLIPSE+trial&amp;index=1&amp;md5=233dc5504f3375cdeeed7cb93125e8cb\">ECLIPSE trial<\/a>, a 10,000-plus patient study, is currently underway to evaluate the performance of Guardant Health\u2019s blood test to detect colorectal cancer in an average-risk adult population.<sup>1<\/sup> If successful, Guardant Health expects data from the trial will support a premarket approval (PMA) submission to the FDA. Despite the incredible pressure that the pandemic put on enrolling patients into the study, which requires patients to consent to undergo an invasive, inpatient colonoscopy procedure, the trial is expected to complete enrollment by the end of 2021. The test is intended to offer a non-invasive, patient-friendly blood testing option that could bridge the gap to the Centers of Disease Control\u2019s (CDC) target compliance goal of 80 percent.<sup>2,3<\/sup><\/p>\n<p>\nToday, it is estimated that only 66% of adults 50 years and older<sup>3<\/sup> are screened despite compelling evidence that routine cancer screening can reduce colorectal cancer mortality, the second leading cause of cancer death.<sup>3 <\/sup>The problem is expected to get worse. The <i>Journal of the American Medical Association<\/i> recently predicted that COVID-19\u2013related reductions in care utilization may result in an estimated 1.2 to 2 million fewer colorectal cancer screenings between 2020 and 2023.<sup>4 <\/sup><\/p>\n<p>\nColorectal cancer is on the rise for younger adults too. The U.S. Preventative Services Task Force (USPSTF) recently lowered the recommended age to start screening from 50 to 45.<sup>5<\/sup> This increases the pool of people who need to be screened by an additional 21 million Americans aged 45 to 49.<sup>6<\/sup> By 2030, it is expected that colorectal cancer will be the leading cause of cancer related death for those aged 20 to 49, making colorectal cancer screening increasingly a priority for all Americans.<sup>7<\/sup><\/p>\n<p>\n\u201cGiven what we have learned during the pandemic about its detrimental impact on cancer screening and healthcare disparities among underserved communities, it has become abundantly clear that a non-invasive, patient-friendly blood test to routinely screen for colorectal cancer is desperately needed,\u201d said Helmy Eltoukhy, Guardant Health CEO. \u201cWe look forward to recognizing the exceptional performance of the institutions participating in our ECLIPSE trial who have worked tirelessly to conclude this trial so that one day soon we can offer patients a more accessible solution for routine colorectal cancer screening. We are proud to stand together with Fight CRC to not only honor these investigators, but to also recognize the incredible dedication of the Fight CRC advocates for their unwavering commitment to CRC screening during these difficult times.\u201d\n<\/p>\n<p>\nTo learn more about CRC screening and the importance of raising awareness of colorectal cancer screening, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ffightcolorectalcancer.org%2F&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=FightCRC.org&amp;index=2&amp;md5=21279ccd09ca30473569026ed6de12a0\">FightCRC.org<\/a>. To learn more about the ECLIPSE trial, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fguardanthealth.com%2Feclipse%2F&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=guardanthealth.com%2Feclipse%2F&amp;index=3&amp;md5=d2ba6b7e68c1af86e3a333c2ee0c8d26\">guardanthealth.com\/eclipse\/<\/a>.\n<\/p>\n<p><b>About Fight Colorectal Cancer <\/b><\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ffightcolorectalcancer.org%2F&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=Fight+Colorectal+Cancer&amp;index=4&amp;md5=b032eece0b81e3b534c411ae38dc6463\">Fight Colorectal Cancer<\/a> (Fight CRC) is a leading patient-empowerment and advocacy organization in the United States, providing balanced and objective information on colon and rectal cancer research, treatment, and policy. We are relentless champions of hope, focused on funding promising, high-impact research endeavors while equipping advocates to influence legislation and policy for the collective good.\n<\/p>\n<p><b>About Guardant Health<\/b><\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fguardanthealth.com&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=Guardant+Health&amp;index=5&amp;md5=92327fa070bb6b7e326c1a72fe1b5ca6\">Guardant Health<\/a> is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360<sup>\u00ae<\/sup>, Guardant360 CDx, Guardant360 TissueNext\u2122, Guardant360 Response\u2122, and GuardantOMNI<sup>\u00ae<\/sup> tests for advanced stage cancer patients, and Guardant Reveal\u2122 for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.\n<\/p>\n<p><b>References<\/b><\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nGuardant Health, Inc. October 2019. <i>Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)<\/i>. Identifier NCT04136002. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04136002&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04136002&amp;index=6&amp;md5=baa4f6b604b7ebb1418f38e0148d1165\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04136002<\/a><\/li>\n<li>\nCenters for Disease Control (CDC). Increasing Quality Colorectal Cancer Screening: An Action Guide for Working with Health Systems. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fcrccp%2Fpdf%2Fcolorectalactionguide.pdf&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fcrccp%2Fpdf%2Fcolorectalactionguide.pdf&amp;index=7&amp;md5=838aa5f54107a24c482581af7a161b9c\">https:\/\/www.cdc.gov\/cancer\/crccp\/pdf\/colorectalactionguide.pdf<\/a>. Accessed online July 8, 2021.\n<\/li>\n<li>\nAmerican Cancer Society: Colorectal Cancer Facts &amp; Figures 2020-2022. Available at: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cancer.org%2Fcontent%2Fdam%2Fcancer-org%2Fresearch%2Fcancer-facts-and-statistics%2Fcolorectal-cancer-facts-and-figures%2Fcolorectal-cancer-facts-and-figures-2020-2022.pdf&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.cancer.org%2Fcontent%2Fdam%2Fcancer-org%2Fresearch%2Fcancer-facts-and-statistics%2Fcolorectal-cancer-facts-and-figures%2Fcolorectal-cancer-facts-and-figures-2020-2022.pdf&amp;index=8&amp;md5=d90f6308144c4cc66e5ed4d9445b84f1\">https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/colorectal-cancer-facts-and-figures\/colorectal-cancer-facts-and-figures-2020-2022.pdf<\/a>. Accessed online July 8, 2021.\n<\/li>\n<li>\nIssaka R, Taylor P, Baxi A, et al. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic. <i>JAMA Network<\/i>. 2021; 4(4): e216454.\n<\/li>\n<li>\nFinal Recommendation Statement: Colorectal Cancer Screening. US Preventive Services Task Force. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf%2Frecommendation%2Fcolorectal-cancer-screening&amp;esheet=52462565&amp;newsitemid=20210720005424&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf%2Frecommendation%2Fcolorectal-cancer-screening&amp;index=9&amp;md5=9f323b330c9ecda27584eba26aa30e11\">https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/colorectal-cancer-screening<\/a>. Published May 18, 2021. Accessed online July 8, 2021.\n<\/li>\n<li>\nLiang P, Allison J, Ladabaum U, Martinez M, et al. Potential Intended and Unintended Consequences of Recommending Initiation of Colorectal Cancer Screening at Age 45 Years. <i>Gastroenterology<\/i>. Oct 2018. Volume 155, Issue 4, Pages 950-954. doi:10.1053\/j.gastro.2018.08.019.\n<\/li>\n<li>\nRahib L, Wehner MR, Matrisian LM, Nead KT, et al. Estimated Projection of US Cancer Incidence and Death to 2040. <i>JAMA Network<\/i>. 2021;4(4):e214708. doi:10.1001\/jamanetworkopen.2021.4708\n<\/li>\n<\/ol>\n<p>\n\u00a0\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210720005424\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210720005424\/en\/<\/a><\/span><\/p>\n<p><b>Fight CRC<br \/>\n<\/b><br \/>Elizabeth Jordan and Danielle Ripley-Burgess<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:media@fightcrc.org\">media@fightcrc.org<br \/>\n<\/a><br \/>(636) 544-7113\n<\/p>\n<p><b>Guardant Health<br \/>\n<\/b><br \/>Anna Czene<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:press@guardanthealth.com\">press@guardanthealth.com<br \/>\n<\/a><br \/>Julie Johnson<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:julie.johnson@uncappedcommunications.com\">julie.johnson@uncappedcommunications.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California Missouri<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Oncology Medical Devices<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210720005424\/en\/828061\/3\/GuardantHealthLogo_TM_RGB-2C.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210720005424\/en\/892497\/3\/FightCRC_PrimaryLogo_RGB_%281%29.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic Selected Recipients of the New \u201cBack to Screening Award for Research Advocacy Excellence\u201d will be Honored at Fight Colorectal Cancer\u2019s \u201cPath to a Cure\u201d Event in December 2021 SPRINGFIELD, Mo. &amp; REDWOOD CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Fight Colorectal Cancer (Fight CRC), the nation&#8217;s leading colorectal cancer (CRC) patient advocacy organization, and Guardant Health, Inc. (Nasdaq: GH), a leader in precision oncology, will be recognizing clinical researchers and advocates who have demonstrated exceptional leadership during the pandemic in getting people back to routine colorectal cancer screening. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210720005424\/en\/ The award, called \u201cBack to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-515006","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic Selected Recipients of the New \u201cBack to Screening Award for Research Advocacy Excellence\u201d will be Honored at Fight Colorectal Cancer\u2019s \u201cPath to a Cure\u201d Event in December 2021 SPRINGFIELD, Mo. &amp; REDWOOD CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Fight Colorectal Cancer (Fight CRC), the nation&#8217;s leading colorectal cancer (CRC) patient advocacy organization, and Guardant Health, Inc. (Nasdaq: GH), a leader in precision oncology, will be recognizing clinical researchers and advocates who have demonstrated exceptional leadership during the pandemic in getting people back to routine colorectal cancer screening. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210720005424\/en\/ The award, called \u201cBack to &hellip; Continue reading &quot;Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-20T12:13:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic\",\"datePublished\":\"2021-07-20T12:13:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/\"},\"wordCount\":1181,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/\",\"name\":\"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-07-20T12:13:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/","og_locale":"en_US","og_type":"article","og_title":"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic - Market Newsdesk","og_description":"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic Selected Recipients of the New \u201cBack to Screening Award for Research Advocacy Excellence\u201d will be Honored at Fight Colorectal Cancer\u2019s \u201cPath to a Cure\u201d Event in December 2021 SPRINGFIELD, Mo. &amp; REDWOOD CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Fight Colorectal Cancer (Fight CRC), the nation&#8217;s leading colorectal cancer (CRC) patient advocacy organization, and Guardant Health, Inc. (Nasdaq: GH), a leader in precision oncology, will be recognizing clinical researchers and advocates who have demonstrated exceptional leadership during the pandemic in getting people back to routine colorectal cancer screening. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210720005424\/en\/ The award, called \u201cBack to &hellip; Continue reading \"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-20T12:13:01+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic","datePublished":"2021-07-20T12:13:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/"},"wordCount":1181,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/","name":"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-07-20T12:13:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210720005424r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fight-colorectal-cancer-and-guardant-health-join-forces-to-recognize-excellence-in-overcoming-challenges-to-colorectal-cancer-screening-during-pandemic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=515006"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515006\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=515006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=515006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=515006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}